KRAS and lung adenocarcinoma: Analysis of a well-validated mouse model of KRAS-mutant lung adenocarcinoma revealed that tumors showed significant activation of NF-κb and furthermore that these tumors were dependent upon NF-κb activity for tumor maintenance3.